Table 2

Demographic, clinical, and medication data of patients in probiotic and control groups
Characteristics % Control group N = 15
Male, n (%) 9 (36%) 4 (27%)
Female, n (%) 16 (64%) 11 (73%)
Age, years 52.0 ± 10.9 51.7 ± 12.1
Body weight, kg 105.6 ± 16.2 102.4 ± 14.4
Body mass index, kg/m2 37.7 ± 4.3 36.3 ± 4.1
Stage I, n 4 3
Stage II, n 12 8
Stage III, n 9 4
Systolic BP, mm Hg 134.0 ± 8.0 131.4 ± 6.6
Stage I, n 2 3
Stage II, n 16 8
Stage III, n 7 4
Diastolic BP, mm Hg 82.4 ± 6.1 82.1 ± 5.8
Drugs used, n (%) 21 (84%) 12 (80%)
Ca antagonist 4 2
Beta-blocker 4 3
ACE inhibitor 12 7
Diuretics 2 1
Others 2 1
Smokers, n (%) 3 2

Data are presented as mean ± standard deviation unless otherwise noted. Fisher’s exact test and t-test: There were no statistical differences between any indices in the two patient groups. BMI scale: overweight = BMI of 25–29.9 kg/m2; grade 2 overweight (commonly called obesity) = BMI of 30–39.9 kg/m2; grade 3 overweight (commonly called severe or morbid obesity) = BMI ≥40 kg/m2. (NORIP, http://www.furst.no/norip/ webcite). Blood pressure (BP) scale: Grade 1 hypertension = systolic blood pressure (SBP) 140–159 and/or diastolic blood pressure (DBP) 90–99; Grade 2 hypertension = SBP 160–179 and/or DBP 100–109; Grade 3 hypertension = SBP ≥180 and/or DBP ≥110 (28).

Sharafedtinov et al.

Sharafedtinov et al. Nutrition Journal 2013 12:138   doi:10.1186/1475-2891-12-138

Open Data